The Cryo-immunologic effect: A therapeutic advance in the treatment of glioblastomas?

Neurochirurgie. 2020 Dec;66(6):455-460. doi: 10.1016/j.neuchi.2020.06.135. Epub 2020 Oct 10.

Abstract

The immunotherapy of cerebral glioblastoma has become a hot topic. Immune checkpoint blockade antibodies have progressively acquired a role in the management of malignant tumors. A multimodal approach using surgery, radiotherapy, chemotherapy in combination with immunotherapy represent a potent weapon against glioblastomas. In parallel, clinical applications of cryotherapy-freezing tumors based on repetition of rapid freeze-slow thaw cycle-for various cancers such as skin, lung, breast, esophagus, hepatic, kidney, prostate and bone tumors were developed. The future immunomodulatory approaches might be combined with brain tumors cryoablation to increase the cryoimmune response. The objective of this study was to analyze from the literature the relationship between cerebral cryosurgery and immunomodulation using PRISMA method. The animals' studies demonstrate the dendritic cells maturation and activation with the enhancement of antigen-presenting function after cryotherapy suggesting the potential usefulness of the association of cryotherapy and immunomodulator in the management of gliomas.

Keywords: Brain Oncology; Brain tumors; Cryotherapy; Cryothérapie; Imagerie guidée par IRM; Immunotherapie; Immunotherapy; MRI imaging guided; Oncologie cérébrale; Tumeurs cérébrales.

Publication types

  • Review

MeSH terms

  • Brain Neoplasms / therapy*
  • Combined Modality Therapy
  • Cryosurgery / methods*
  • Glioblastoma / therapy*
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use
  • Immunotherapy / methods*
  • Neurosurgical Procedures / methods*

Substances

  • Immune Checkpoint Inhibitors